Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

OraVerse

Canada Type III Ongoing · initiated 2025-11-13

Establishment/Site licensing. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for …

Medical Products Laboratories, Inc.

US Class II Ongoing · initiated 2025-11-12

Microbial contamination of a non-sterile product - microorganism found to be pseudomonas lactis

Life Brand Magnesium Bisglycinate 200mg

Canada Type III Ongoing · initiated 2025-11-12

Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…

Dr. Reddy's Laboratories, Inc.

US Class III Ongoing · initiated 2025-11-11

Sub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit.

FOLLTROPIN-V

Canada Type II Ongoing · initiated 2025-11-10

Product quality. Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health c…

Nitrous Oxide Charger

Canada Type I Ongoing · initiated 2025-11-10

Product safety. Do not inhale nitrous oxide products for recreational purposes.Seek immediate medical attention from a health care professional (physician, nurs…

Teva Pharmaceuticals USA, Inc

US Class III Ongoing · initiated 2025-11-07

Defective Container - A defect in the side-seal which allows leakage of product.

DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP

Canada Type II Ongoing · initiated 2025-11-07

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Fresenius Kabi USA, LLC

US Class I Ongoing · initiated 2025-11-06

Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

CYCLODX

Canada Type III Ongoing · initiated 2025-11-06

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Lupin Pharmaceuticals Inc.

US Class II Ongoing · initiated 2025-11-05

Defective container - seal not adhering to bottles

Nitrous Oxide Chargers

Canada Type I Ongoing · initiated 2025-11-05

Unauthorized product. Do not inhale nitrous oxide products for recreational purposes.Seek immediate medical attention from a health care professional (physician…

Proactiv / Proactiv + BPO products

Canada Type II Ongoing · initiated 2025-11-05

Product safety. Verify if your product is affected.Stop taking the product. Consult your healthcare provider for any health concerns.Contact the recalling firm …

Blossom Pharmaceuticals

US Class II Ongoing · initiated 2025-10-31

cGMP deviations

Blossom Pharmaceuticals

US Class II Ongoing · initiated 2025-10-31

cGMP deviations

Blossom Pharmaceuticals

US Class II Ongoing · initiated 2025-10-31

cGMP deviations

Blossom Pharmaceuticals

US Class II Ongoing · initiated 2025-10-31

cGMP deviations

Blossom Pharmaceuticals

US Class II Ongoing · initiated 2025-10-31

cGMP deviations

Blossom Pharmaceuticals

US Class II Ongoing · initiated 2025-10-31

cGMP deviations

Blossom Pharmaceuticals

US Class II Ongoing · initiated 2025-10-31

cGMP deviations

Cipla Limited

US Class II Ongoing · initiated 2025-10-31

Failed Stability Specifications: Observed OOS results: eg results for colour index

Blossom Pharmaceuticals

US Class II Ongoing · initiated 2025-10-31

cGMP deviations

Blossom Pharmaceuticals

US Class II Ongoing · initiated 2025-10-31

cGMP deviations

Blossom Pharmaceuticals

US Class II Ongoing · initiated 2025-10-31

cGMP deviations

Blossom Pharmaceuticals

US Class II Ongoing · initiated 2025-10-31

cGMP deviations